"Artificial Pancreas" Using Available Commercial Technology Shows Promise

Clinical researchers at Cambridge University have been testing the effectiveness of combining commercial continuous glucose monitors with insulin pumps via a proprietary closed-loop algorithm developed by the researchers.. The study, performed on type 1 diabetic pediatric patients using pumps and meters from Smiths Medical, Medtronic, and Abbott, has demonstrated a significant overnight glucose management improvement over continuous drip pumps.

In the new study, 17 children and

• » Read Full Story